A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors

Maurice A. Wright, Geraldine Morrison, Pengxin Lin, Gregory D. Leonard, Dat Nguyen, Xaiodu Guo, Eva Szabo, Jon L. Hopkins, Jorge P. Leguizamo, Nancy Harold, Suzanne Fioravanti, Barbara Schuler, Brian P. Monahan, M. Wasif Saif, Mary G. Quinn, Janet Pang, Jean L. Grem

Research output: Contribution to journalArticle

5 Scopus citations

Fingerprint Dive into the research topics of 'A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences